Dear Shareholder, 2017 marks the first year since 2014 that the company has published financial information. You can now find financial information for 2015 and 2016 on our website, Kelyniam.com. Reporting financial information is just one example of the many positive changes happening at Kelyniam. I am pleased to report that year over year revenues...Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has signed a multi-year distribution agreement with a leading medical device distributor in the neuroscience market. Dr. Mark Smith, Kelyniam’s Vice President of Sales said, “This agreement is in alignment with our sales strategy of building long-term relationships with...Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has hired Ross Bjella as Chairman and Chief Executive Officer. The company had recently appointed Chris Breault as Chief Operating Officer after the former President, Tennyson Anthony, left the company in April of this year. The company has also...Read More
Canton, CT, June 3, 2014 (GLOBE NEWSWIRE) — Kelyniam Global Inc, (OTC: KLYG), a prominent manufacturer of custom cranial implants, today reported that the company generated net income of $71,205 in the first quarter of 2014. Compared with first quarter 2013, net sales increased 23% from $437,415 to $540,286, as a result of increased market...Read More
Kelyniam Global Inc., a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% vs. sales of $1,206,227 in 2012. The Kelyniam product fit and quick turnaround has captured the attention of surgeons throughout the United States. The revenue increase reflects the continued rollout in many additional...Read More
Kelyniam Global Inc. (OTC: KLYG) (“the company”) is pleased to announce that it has posted its first ever quarterly profit, for the quarter ending June 30, 2013. Net income for the second quarter was $6,608. Sales in the second quarter were $593,355, up 35% from $438,415 in the first quarter 2013. Year to date sales...Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments